Vesicle-mediated membrane fusion designed to place the signal at the tumor surface, with adaptive precision control.

Programmable safety and activation logic designed to govern when, where, and how the platform acts.

The governing framework designed to coordinate every layer as one context-aware system.

NeoTag, Atraxis, AegisCore and StratIQ: four patent-pending platforms designed to work in concert as one non-genetic, non-viral system for immune recognition.